FY20 consolidated facilities task order d

Active Awarded Last action

Contract number
75N91020F00013
Awardee
Awarding agency
Obligated
$19,152,283

Award facts

Contract value 100% obligated
$19,152,282.95 Current and potential, with all options
Completion date 85% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00038 -$809,852
Terminate for Convenience P00037 · EOI::implementing the presidents department of government efficiency cost efficiency initiative (march 19, 2025)::EOI $0
Other Administrative Action P00036 $0
Other Administrative Action P00035 $0
Other Administrative Action P00034 $0
Other Administrative Action P00033 $0
Other Administrative Action P00032 $0
Other Administrative Action P00031 $0
Other Administrative Action P00030 $0
Other Administrative Action P00029 $0
Other Administrative Action P00028 $0
Other Administrative Action P00027 $0
Other Administrative Action P00026 $0
Other Administrative Action P00025 $0
Other Administrative Action P00024 $0
Supplemental Agreement for work within scope P00023 $34,083
Other Administrative Action P00022 $0
Other Administrative Action P00021 $0
Supplemental Agreement for work within scope P00020 · FY20 consolidated facilities task order d - MOD 020 $0
Supplemental Agreement for work within scope P00019 · FY20 consolidated facilities task order d - MOD 019 $185,168
Other Administrative Action P00018 $0
Other Administrative Action P00017 · FY20 consolidated facilities task order d - MOD 017 $155,455
Other Administrative Action P00016 · FY20 consolidated facilities task order d - MOD 016 $725,607
Other Administrative Action P00015 · FY20 consolidated facilities task order d - MOD 015 $955,436
Other Administrative Action P00014 · FY20 consolidated facilities task order d - MOD 014 $0
Other Administrative Action P00012 $99,710
Other Administrative Action P00011 $0
Other Administrative Action P00013 $820,277
Other Administrative Action P00010 $0
Supplemental Agreement for work within scope P00009 $49,670
Supplemental Agreement for work within scope P00008 $0
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $64,862
Other Administrative Action P00003 $0
Supplemental Agreement for work within scope P00002 $378,097
Other Administrative Action P00001 $37,019
Original award $16,456,751
Show all 39

About this award

Written by GovTribe AI ·

The National Cancer Institute (NCI) awarded a delivery order valued at approximately $19.2 million to Leidos Biomedical Research Inc. on August 25, 2020, with an ultimate completion date of December 2, 2027. This cost-plus-fixed-fee contract is part of the FY20 Consolidated Facilities task order program and does not include a small business set-aside designation. The work will be performed at the Frederick National Laboratory for Cancer Research in Frederick, Maryland, where Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor. The contract supports NCI's biomedical research and facilities infrastructure initiatives, leveraging the contractor's extensive capabilities in cancer research, clinical trials, facility management, and advanced scientific and technical services.

Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc., a major defense and civilian federal contractor headquartered in Reston, Virginia. As an FFRDC contractor for the NCI and broader National Institutes of Health, Leidos Biomedical Research Inc. provides comprehensive research support and facilities services across multiple scientific domains. The company's contract portfolio demonstrates proven expertise in gene therapy development, infectious disease research, clinical trial support, therapeutic agent manufacturing, and specialized laboratory testing. This delivery order aligns with the NCI's mission to support critical cancer research infrastructure and represents a multi-year commitment reflecting the contractor's significant role in federal biomedical research and development efforts.

Quick answers

Who was awarded contract 75N91020F00013?

75N91020F00013 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 25, 2020.

How much is contract 75N91020F00013 worth?

The government has obligated $19,152,283 on 75N91020F00013.

Is contract 75N91020F00013 an order under another contract?

Yes. 75N91020F00013 is a delivery order under 75N91019D00024, an indefinite delivery contract.

Was contract 75N91020F00013 competed?

The extent of competition for 75N91020F00013 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login